Profound Medical (PROF) said Friday that it priced an underwritten public offering of about 4.7 million common shares at $7.50 per share to raise gross proceeds of about $35 million.
The company granted the underwriters a 30-day option to purchase up to an additional 700,005 common shares at the same offering price.
Profound Medical expects to close the offering on or about Tuesday and said proceeds will be used to fund the commercialization of its Tulsa-Pro and Sonalleve systems and for general working capital.
Price: 8.03, Change: -0.16, Percent Change: -1.95
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。